SeenewsSeenews
Search
Seenews
AlertsSeenewsSeenews
Searchclose
TOPICS
arrow
COUNTRIES
arrow
INDUSTRY
arrow
Economy
arrow
Browse Economy
Mix and match your focus countries with our advanced search
Investments
arrow
Browse Investments
Mix and match your focus countries with our advanced search
Deals
arrow
Browse Deals
Mix and match your focus countries with our advanced search
Tech
arrow
Browse Tech
Mix and match your focus countries with our advanced search
Green
arrow
Browse Green
Mix and match your focus countries with our advanced search
0/5
You have 5 free articles left this month
You have 0/5 free articles
Sign up to get 5 more free articles this month
SIGN UP
arrow
LOGIN
arrow

N. Macedonia's Alkaloid cons net profit rises 8% in 2023

Feb 28, 2024, 11:26:16 AMArticle by Dragana Petrushevska
share
February 28 (SeeNews) - North Macedonia's biggest pharmaceutical company Alkaloid [MSE:ALK] increased its consolidated net profit 8% year-on-year to 1.6 billion denars ($28.1 million/26 million euro) in 2023, it said on Wednesday.

N. Macedonia's Alkaloid cons net profit rises 8% in 2023

Sales revenue went up 16% year-on-year, reaching 16.5 billion denars in 2023, Alkaloid said in an annual financial statement filed with the Skopje bourse.

Domestic sales added 13% on the year to 5.2 billion denars last year, while sales abroad rose 17% to 11.3 billion denars.

The cost of goods sold was 14% higher on the year at 8.9 billion denars in the year under review.

The company's shares traded at an average price of 20,700 denars on Tuesday, latest bourse data showed.

Alkaloid has two subsidiaries in North Macedonia and 19 subsidiaries and two representative offices abroad - in Serbia, Montenegro, Kosovo, Albania, Bosnia and Herzegovina, Croatia, Slovenia, Romania, Switzerland, Bulgaria, Turkey, Ukraine, Russia, the U.S. and the UK.

(1 euro = 61.61 denars)

Your complete guide to the emerging economies of Southeast Europe. From latest news to bespoke research – the big picture at the tip of your fingers.